Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-5f745c7db-hj587 Total loading time: 0 Render date: 2025-01-06T13:06:43.708Z Has data issue: true hasContentIssue false

Chapter 21 - Genetic Explanations for the Association between Cannabis and Schizophrenia

from Part VI - Cannabinoids and Schizophrenia: Aetiopathology and Treatment Implications

Published online by Cambridge University Press:  12 May 2023

By
Sarah M. C. Colbert  and
Emma C. Johnson
Edited by
Deepak Cyril D'Souza ,
David Castle  and
Sir Robin Murray
Deepak Cyril D'Souza
Affiliation:
Staff Psychiatrist, VA Connecticut Healthcare System; Professor of Psychiatry, Yale University School of Medicine
David Castle
Affiliation:
University of Tasmania, Australia
Sir Robin Murray
Affiliation:
Honorary Consultant Psychiatrist, Psychosis Service at the South London and Maudsley NHS Trust; Professor of Psychiatric Research at the Institute of Psychiatry
Get access

Summary

The high comorbidity between cannabis use and schizophrenia may be partially attributable to shared genetic liability. Here, we review evidence from family-based studies, polygenic score approaches, genome-wide genetic correlations, and causal inference methods using genetic instruments. Overall, most studies point to a modest but significant amount of genetic overlap between cannabis use and schizophrenia, which appears to be shared across a range of levels of cannabis involvement. Future studies should seek to identify co-morbid cases in genome-wide association studies and quantify the amount of genetic overlap when co-morbid cases are removed.

Keywords

heritabilitydiscordant twin designgenome-wide association studygenetic correlationpolygenic scoresMendelian randomization
Type
Chapter
Information
Marijuana and Madness , pp. 216 - 224
Publisher: Cambridge University Press
Print publication year: 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abdellaoui, A., Smit, D. J. A., van den Brink, W., et al. (2021). Genomic relationships across psychiatric disorders including substance use disorders. Drug Alcohol Depend, 220, 108535.Google Scholar
Andreasen, N. C. (1989). The American concept of schizophrenia. Schizophr Bull, 15, 519–531.Google Scholar
Andréasson, S., Allbeck, P., Engström, A., et al. (1987). Cannabis and schizophrenia: A longitudinal study of Swedish conscripts. Lancet, 330, 1483–1486.Google Scholar
Arseneault, L., Cannon, M., Witton, J., et al. (2004). Causal association between cannabis and psychosis: Examination of the evidence. Br J Psychiatry, 184, 110–117.Google Scholar
Asarnow, R. F., Nuechterlein, K. H., Fogelson, D., et al. (2001). Schizophrenia and schizophrenia-spectrum personality disorders in the first-degree relatives of children with schizophrenia: The UCLA family study. Arch Gen Psychiatry, 58, 581–588.CrossRefGoogle ScholarPubMed
Baron, M., Gruen, R., Rainer, J. D., et al. (1985). A family study of schizophrenic and normal control probands: Implications for the spectrum concept of schizophrenia. Am J Psychiatry, 142, 447–455.Google Scholar
Boydell, J., Dean, K., Dutta, R., et al. (2007). A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: Implications for the concept of cannabis psychosis. Schizophr Res, 93, 203–210.Google Scholar
Bulik-Sullivan, B. K., Finucane, H. K., Anttila, V., et al. (2015a). An atlas of genetic correlations across human diseases and traits. Nat Genet, 47, 1236.Google Scholar
Bulik-Sullivan, B. K., Loh, P.-R., et al. (2015b). LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet, 47, 291–295.Google Scholar
Carey, C. E., Agrawal, A., Bucholz, K. K., et al. (2016). Associations between polygenic risk for psychiatric disorders and substance involvement. Front Genet, 7, 149.Google Scholar
Degenhardt, L., and Hall, W. (2006). Is cannabis use a contributory cause of psychosis? Can J Psychiatry, 51, 556–565.CrossRefGoogle ScholarPubMed
Demontis, D., Rajagopal, V. M., Thorgeirsson, T. E., et al. (2019). Genome-wide association study implicates CHRNA2 in cannabis use disorder. Nat Neurosci, 22, 1066–1074.Google Scholar
Distel, M. A., Vink, J. M., Bartels, M., et al. (2011). Age moderates non‐genetic influences on the initiation of cannabis use: A twin‐sibling study in Dutch adolescents and young adults. Addiction, 106, 1658–1666.Google Scholar
Ellingson, J. M., Ross, J. M., Winiger, E., et al. (2021). Familial factors may not explain the effect of moderate‐to‐heavy cannabis use on cognitive functioning in adolescents: A sibling‐comparison study. Addiction, 116, 833–844.Google Scholar
Di Forti, M., Quattrone, D., Freeman, T. P., et al. (2019a). The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): A multicentre case-control study. Lancet Psychiatry, 6, 427–436.Google Scholar
Di Forti, M., Sallis, H., Allegri, F., et al. (2014). Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophr Bull, 40, 1509–1517.CrossRefGoogle ScholarPubMed
Di Forti, M., Wu-Choi, B., Quattrone, D., et al. (2019b). The independent and combined influence of schizophrenia polygenic risk score and heavy cannabis use on risk for psychotic disorder: A case-control analysis from the EUGEI study. bioRxiv, 844803.Google Scholar
Gage, S. H., Hickman, M., and Zammit, S. (2016). Association between cannabis and psychosis: Epidemiologic evidence. Biol Psychiatry, 79, 549–556.Google Scholar
Gage, S. H., Jones, H. J., Burgess, S., et al. (2017). Assessing causality in associations between cannabis use and schizophrenia risk: A two-sample Mendelian randomization study. Psychol Med, 47, 971–980.CrossRefGoogle Scholar
Giordano, G. N., Ohlsson, H., Sundquist, K., et al. (2015). The association between cannabis abuse and subsequent schizophrenia: A Swedish national co-relative control study. Psychol Med, 45, 407–414.Google Scholar
Hall, W., Stjepanović, D., Caulkins, J., et al. (2019). Public health implications of legalising the production and sale of cannabis for medicinal and recreational use. Lancet, 394, 1580–1590.Google Scholar
Henquet, C., Murray, R., Linszen, D., et al. (2005). The environment and schizophrenia: The role of cannabis use. Schizophr Bull, 31, 608–612.Google Scholar
Hjorthøj, C., Uddin, M. J., Wimberley, T., et al. (2021). No evidence of associations between genetic liability for schizophrenia and development of cannabis use disorder. Psychol Med, 51, 479–484.Google Scholar
Johnson, E. C., Demontis, D., Thorgeirsson, T. E., et al. (2020). A large-scale genome-wide association study meta-analysis of cannabis use disorder. Lancet Psychiatry, 7, 1032–1045.Google Scholar
Johnson, E. C., Hatoum, A. S., Deak, J. D., et al. (2021). The relationship between cannabis and schizophrenia: A genetically informed perspective. Addiction, 116, 3227–3234.Google Scholar
Karcher, N. R., Barch, D. M., Demers, C. H., et al. (2019). Genetic predisposition vs individual-specific processes in the association between psychotic-like experiences and cannabis use. JAMA Psychiatry, 76, 87–94.Google Scholar
Kendler, K. S., McGuire, M., Gruenberg, A. M., et al. (1993). The Roscommon Family Study: III. Schizophrenia-related personality disorders in relatives. Arch Gen Psychiatry, 50, 781–788.Google Scholar
Lynskey, M. T., Heath, A. C., Bucholz, K. K., et al. (2003). Escalation of drug use in early-onset cannabis users vs co-twin controls. JAMA, 289, 427–433.Google Scholar
Maier, W., Lichtermann, D., Minges, J., et al. (1993). Continuity and discontinuity of affective disorders and schizophrenia: Results of a controlled family study. Arch Gen Psychiatry, 50, 871–883.Google Scholar
Marconi, A., Di Forti, M., Lewis, C. M., et al. (2016). Meta-analysis of the association between the level of cannabis use and risk of psychosis. Schizophr Bull, 42, 1262–1269.Google Scholar
McGrath, J., Welham, J., Scott, J., et al. (2010). Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Arch Gen Psychiatry, 67, 440–447.Google Scholar
McGuire, P. K., Jones, P., Harvey, I., et al. (1995). Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis. Schizophr Res, 15, 277–281.Google Scholar
Merikangas, K. R., Li, J. J., Stipelman, B., et al. (2009). The familial aggregation of cannabis use disorders. Addiction, 104, 622–629.CrossRefGoogle ScholarPubMed
Nesvåg, R., Reichborn-Kjennerud, T., Gillespie, N. A., et al. (2017). Genetic and environmental contributions to the association between cannabis use and psychotic-like experiences in young adult twins. Schizophr Bull, 43, 644–653.Google Scholar
O’Connor, L. J., and Price, A. L. (2018). Distinguishing genetic correlation from causation across 52 diseases and complex traits. Nat Genet, 50, 1728–1734.Google Scholar
van Os, J., Bak, M., Hanssen, M., et al. (2002). Cannabis use and psychosis: A longitudinal population-based study. Am J Epidemiol, 156, 319–327.Google Scholar
Pasman, J. A., Verweij, K. J. H., Gerring, Z., et al. (2018). GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia. Nat Neurosci, 21, 1161–1170.Google Scholar
Power, R. A., Verweij, K. J., Zuhair, M., et al. (2014). Genetic predisposition to schizophrenia associated with increased use of cannabis. Mol Psychiatry, 19, 1201.CrossRefGoogle ScholarPubMed
Proal, A. C., Fleming, J., Galvez-Buccollini, J. A., et al. (2014). A controlled family study of cannabis users with and without psychosis. Schizophr Res, 152, 283–288.Google Scholar
Reginsson, G. W., Ingason, A., Euesden, J., et al. (2018). Polygenic risk scores for schizophrenia and bipolar disorder associate with addiction. Addict Biol, 23, 485–492.Google Scholar
Saha, S., Chant, D., Welham, J., et al. (2005). A systematic review of the prevalence of schizophrenia. PLoS Med, 2, e141.Google Scholar
Vaucher, J., Keating, B. J., Lasserre, A. M., et al. (2017). Cannabis use and risk of schizophrenia: A Mendelian randomization study. Mol Psychiatry, 23, 1287.Google Scholar
Veling, W., Mackenbach, J. P., van Os, J., et al. (2008). Cannabis use and genetic predisposition for schizophrenia: A case-control study. Psychol Med, 38, 1251–1256.Google Scholar
Verweij, K. J. H., Abdellaoui, A., Nivard, M. G., et al. (2017). Genetic association between schizophrenia and cannabis use. Drug Alcohol Depend, 171, 117–121.Google Scholar
Vitaro, F., Brendgen, M., and Arseneault, L. (2009). The discordant MZ-twin method: One step closer to the holy grail of causality. Int J Behav Dev, 33, 376–382.Google Scholar
Yung, A. R., Nelson, B., Baker, K., et al. (2009). Psychotic-like experiences in a community sample of adolescents: Implications for the continuum model of psychosis and prediction of schizophrenia. Aust NZ J Psychiatry, 43, 118–128.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×